BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROCE(%) | 3.48 | 13.01 | 2.31 | 37.46 | 59.62 |
What is the latest Return on Capital Employed (ROCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2026 | 3.48 |
| Mar2025 | 13.01 |
| Mar2024 | 2.31 |
| Mar2023 | 37.46 |
| Mar2022 | 59.62 |
How is Return on Capital Employed (ROCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2026 | 3.48 | -73.25 | |
| Mar2025 | 13.01 | 463.20 | |
| Mar2024 | 2.31 | -93.83 | |
| Mar2023 | 37.46 | -37.17 | |
| Mar2022 | 59.62 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹130.5 Cr | -2.2% | -1.6% | -48.2% | Stock Analytics | |
| ADANI ENTERPRISES | ₹403,409.0 Cr | -1.6% | -6% | 30.9% | Stock Analytics | |
| PREMIER ENERGIES | ₹47,655.8 Cr | 0.9% | -5.9% | 2.6% | Stock Analytics | |
| ADITYA INFOTECH | ₹46,131.9 Cr | 7.1% | 4.5% | NA | Stock Analytics | |
| AEGIS LOGISTICS | ₹44,382.2 Cr | -6.9% | 0.3% | 82.3% | Stock Analytics | |
| REDINGTON | ₹26,568.6 Cr | 1.8% | 25.1% | 39.5% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.2% |
-1.6% |
-48.2% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses